Impact of prescription size on statin adherence and cholesterol levels
<p>Abstract</p> <p>Background</p> <p>Therapy with 3-Hydroxy-3-methylglutaryl Co-enzyme A reductase inhibitors (statins) improve outcomes in a broad spectrum of patients with hyperlipidemia. However, effective therapy requires ongoing medication adherence; restrictive ph...
Main Authors: | Mehler Phillip S, Dale Rita A, Krantz Mori J, Batal Holly A, Steiner John F |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | BMC Health Services Research |
Online Access: | http://www.biomedcentral.com/1472-6963/7/175 |
Similar Items
-
Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemia
by: Mansur Antonio P., et al.
Published: (2001-01-01) -
Statin prescription patterns, adherence, and attainment of cholesterol treatment goals in routine clinical care: a Danish population-based study
by: Svensson E, et al.
Published: (2015-02-01) -
Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients
by: Josephine H. Li, et al.
Published: (2014-03-01) -
Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
by: Alwhaibi M, et al.
Published: (2019-12-01) -
Cholesterol, statins, and Alzheimer disease.
by: Alexei R Koudinov, et al.
Published: (2005-03-01)